The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Herbal Supplements
Abstract
The Food and Drug Administration (FDA) classifies herbal preparations as food supplements. New herbal supplements and products are not governed by the strict FDA drug approval process and there is no premarket approval required. The FDA prohibits manufacturers and distributors from marketing adulterated or misbranded products but does not rigorously define safe practices. Scientific evidence related to herbal supplements is limited. Herbal supplements have been associated with adverse reactions and herbal-drug interactions. Information and precautions for 20 common herbal supplements, including St. John's wort, ginseng, echinacea, and ginkgo, are reviewed. Resources for consumers and health care professionals are highlighted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Manufacturers of HDS formulations are not required to conduct preclinical safety and efficacy studies before product marketing.2”
From Ashwagandha-induced liver injury—A case series from India and literature review (2023) · cites this paper as [2]
Citations
Cites
Challenges and guidelines for clinical trial of herbal drugs
Ahmad, S., Parveen, A., Parveen, B., & Parveen, R. (2015) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.168035 · Cited by 259
Brown, A. C. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.11.001 · Cited by 184
Flagged first, then by citations
Research works printed but not linked: 17
- Govindaraghavan, 2015, Quality assessment of medicinal herbs and their extracts: criteria and prerequisites for consistent safety and efficacy of herbal medicines, Epilepsy Behav, 52, 363, 10.1016/j.yebeh.2015.03.004 · DOI
- Smith, 2019, Herbal supplement sales in US increase by 9.4% in 2018, Herbalgram, 123, 62
- Lenssen, 2019, International perspectives on substantiating the efficacy of herbal dietary supplements and herbal medicines through evidence on traditional use, Compr Rev Food Sci Food Saf, 18, 910, 10.1111/1541-4337.12446 · DOI
- Cohen, 2012, Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States, J Gen Intern Med, 27, 51, 10.1007/s11606-011-1828-0 · DOI
- Cohen, 2014, Presence of banned drugs in dietary supplements following FDA recalls, JAMA, 312, 1691, 10.1001/jama.2014.10308 · DOI
- Pereira, 2016, Herbal supplements: widely used, poorly understood, Plast Surg Nurs, 46, 54
- Asher, 2017, Common herbal dietary supplement-drug interactions, Am Fam Physician, 96, 101
- Pruitt, 2018, Herbal supplements: research findings and safety, Nurse Pract, 43, 32, 10.1097/01.NPR.0000531919.99762.85 · DOI
- Schaffer, 2016, Herbal supplements for health promotion and disease prevention, Nurse Pract, 41, 39, 10.1097/01.NPR.0000482381.59982.41 · DOI
- Rashrash, 2017, Prevalence and predictors of herbal medicine use among adults in the United States, J Patient Exp, 4, 108
- Swann, 2016, The history of efforts to regulate dietary supplements in the USA, Drug Test Anal, 8, 271, 10.1002/dta.1919 · DOI
- Jou, 2016, Non-disclosure of complementary and alternative medicine use to primary care physicians: findings from the 2012 national health interview survey, JAMA, 176, 545
- Gardiner, 2008, Herbal and dietary supplement-drug interactions in patients with chronic illnesses, Am Fam Physician, 77, 73
- Kaye, 2014, Critical care medicine and the emerging challenges of dietary supplements, including herbal products, Crit Care Med, 42, 1014, 10.1097/CCM.0000000000000174 · DOI
- de Souza Silva, 2014, Use of herbal medicines by elderly patients: a systematic review, Arch Gerontol Geriatr Suppl, 59, 227, 10.1016/j.archger.2014.06.002 · DOI
- Amer, 2015, Safety of popular herbal supplements in lactating women, J Hum Lact, 31, 348, 10.1177/0890334415580580 · DOI
- Palleria, 2013, Pharmacokinetic drug-drug interaction and their implication in clinical management, J Res Med Sci, 18, 601
Cited by
Sorted by citations
Ashwagandha-induced liver injury—A case series from India and literature review
Philips, C. A., Valsan, A., Theruvath, A. H., Ravindran, R., Oommen, T. T., Rajesh, S., Bishnu, S., Augustine, P., & India, O. B. O. T. L. R. C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000270 · Cited by 62
Metadata
- Authors
- Williams, C. T.
- Venue
- Nursing Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 56
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0029-6465 (ISSN-L)
- OpenAlex
- W3129095040
- Cited by
- 35
- References
- 2
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 4 · 2021: 2
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nursing Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry Medicinal Plant Applications
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutrition and Health Studies
- Keywords
- herbal supplements, dietary supplements, FDA regulation, premarket approval, misbranding, adverse effects, herb-drug interactions, Hypericum perforatum, ginseng, Echinacea, Ginkgo biloba, consumer information
- MeSH terms
- Panax, Humans, Phytotherapy, Tinnitus, United States, United States Food and Drug Administration, Dietary Supplements, Ginkgo biloba, Kava, Hypericum, Plant Preparations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
